REVVITY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.5 USD | -0.57% |
|
+0.64% | -7.14% |
| Apr. 25 | Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024 | CI |
| Apr. 25 | Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing | CI |
ETFs positioned on Revvity, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 17.77% | 13 M€ | -.--% | ||
| 1.41% | 2 M€ | +6.77% | ||
| 1.01% | 2 M€ | -.--% | ||
| 0.93% | 96 M€ | -1.45% | ||
| 0.75% | 8 M€ | +2.44% | ||
| 0.60% | 18 M€ | +3.79% | - | |
| 0.22% | 9 M€ | -.--% | - | |
| 0.18% | 10 M€ | +5.96% | ||
| 0.17% | 5 M€ | -72.95% | - | |
| 0.13% | 52 M€ | +6.98% | ||
| 0.09% | 8 M€ | +3.41% | - | |
| 0.09% | 33 M€ | +0.25% | - | |
| 0.09% | 18 M€ | +3.41% | - | |
| 0.09% | 219 M€ | +17.17% | - | |
| 0.09% | 1,448 M€ | -.--% | - | |
| 0.07% | 330 M€ | -.--% | - | |
| 0.06% | 27 M€ | +17.28% | - | |
| 0.06% | 9 M€ | +2.75% | - | |
| 0.06% | 736 M€ | +6.09% | ||
| 0.06% | 125 M€ | +4.43% | - | |
| 0.06% | 6 M€ | +17.98% | - | |
| 0.06% | 276 M€ | +11.40% | - | |
| 0.05% | 1 M€ | +0.04% | ||
| 0.05% | 2,658 M€ | +10.56% | - |
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Calendar
2024-04-29
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
101.5
USD
Average target price
123.2
USD
Spread / Average Target
+21.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.14% | 12.54B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- RVTY Stock
- Funds and ETFs Revvity, Inc.
